Sort
21,453 grants matching “tuberculosis”
Investigating the impact of helminth infection on microbioma composition and innate immunity generated during HepB vaccination.
$287,394Rafick-Pierre Sekaly · Drexel University · U19 · FY2017 · AI
GENE EXPRESSION OF M.TUBERCULOSIS WITHIN MACROPHAGES
$287,349Wadsworth Center · R01 · FY2001 · AI
GENES FOR METHY1-BRANCHED WALL LIPIDS AND TUBERCULOSIS
$287,268Ohio State University · R01 · FY2001 · AI
Enabling point-of-care molecular diagnostics by developing an adaptive PCR instrument and on-demand kit reagents
$287,251Elliott Paul Dawson · Bioventures, Inc. · R42 · FY2017 · HG
Animal Models Core
$287,243Soumya Raychaudhuri · Brigham And Women'S Hospital · U19 · FY2015 · AI
Clinical Decision Support to Promote Immigrant Child Health Screening
$287,197Katherine M Yun · Children'S Hosp Of Philadelphia · R21 · FY2022 · AI
Tuberculosis & HIV Co-Infection Training Program in Kenya
$287,132Thomas R Hawn · University Of Washington · D43 · FY2022 · TW
The roles of biologically relevant ncRNAs
$287,071Sarah M Fortune · Harvard School Of Public Health · U19 · FY2013 · AI
Recognition of Mtb-infected cells by CD8+ T lymphocytes
$286,900Oregon Health And Science University · R01 · FY2002 · AI
Tuberculosis & HIV Co-Infection Training Program in Kenya
$286,900Thomas R Hawn · University Of Washington · D43 · FY2023 · TW
TB/MDR-TB Research training and Capacity Strengthening for LMIC in Southeast Asia Phase II
$286,869Virasakdi Chongsuvivatwong · Prince Of Songkla University · D43 · FY2024 · TW
Development and application of pediatric-specific blood transcriptional modules across diverse geographical settings through public data mining
$286,791Thomas Lafayette Hagan · Cincinnati Childrens Hosp Med Ctr · R21 · FY2025 · AI
Tuberculosis & HIV Co-Infection Training Program in Kenya
$286,730Thomas R Hawn · University Of Washington · D43 · FY2024 · TW
TRANSMISSION OF PAUCIBACILLARY AND DRUG RESISTANT TB
$286,712Stanford University · U01 · FY2000 · AI
Tuberculosis & HIV Co-Infection Training Program in Kenya
$286,554Thomas R Hawn · University Of Washington · D43 · FY2025 · TW
Mechanisms Leading to Tuberculosis-Related Respiratory Sequelae in Adolescents
$286,552Silvia Shinpei Chiang · Rhode Island Hospital · P20 · FY2025 · GM
Live biotherapeutics for the treatment of nontuberculous mycobacteria lung infection associated with cystic fibrosis
$286,530Anthony F Cann · Scibac, Inc. · R43 · FY2019 · HL
Host biomarkers for M. tuberculosis infection activity in HIV-infected persons
$286,465Jacqueline Michele Achkar · Albert Einstein College Of Medicine · R01 · FY2018 · AI
Administrative Core
$286,434David Branch Moody · Brigham And Women'S Hospital · U19 · FY2015 · AI
STRUCTURE BASED DRUG DESIGN
$286,403University Of California San Francisco · R01 · FY2000 · CA
VACCINE DEVELOPMENT IN TUBERCULOSIS
$286,364Forsyth Institute · R01 · FY2003 · AI
Elucidating the biosynthesis of mycofactocin, an unknown molecule essential for M. tuberculosis
$286,351John A Latham · University Of Denver (Colorado Seminary) · R01 · FY2020 · GM
Elucidating the biosynthesis of mycofactocin, an unknown molecule essential for M. tuberculosis
$286,351Sandra S. Eaton · University Of Denver (Colorado Seminary) · R01 · FY2021 · GM
Elucidating the biosynthesis of mycofactocin, an unknown molecule essential for M. tuberculosis
$286,323John A Latham · University Of Denver (Colorado Seminary) · R01 · FY2018 · GM
Elucidating the biosynthesis of mycofactocin, an unknown molecule essential for M. tuberculosis
$286,323John A Latham · University Of Denver (Colorado Seminary) · R01 · FY2019 · GM